T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells

Contact hypersensitivity (CHS) is a T cell-mediated response to hapten sensitization of the epidermis. The roles of CD4+ and CD8+ T cells in CHS have remained unclear, however, as studies to define either subset as the T cells mediating CHS have provided conflicting results. The goal of this study was to correlate the in vivo function of CD4+ and CD8+ T cells in CHS with the cytokines produced by each T cell population. Antibody-mediated depletion of CD4+ T cells before sensitization of BALB/c mice with 2,4-dinitrofluorobenzene (DNFB) or oxazolone (Ox) resulted in increased and prolonged CHS responses, indicating CD4+ T cells as negative regulators of the response. Depletion of CD8+ T cells resulted in low or abrogated responses, indicating CD8+ T cells as the effector cells in CHS. Sensitization with DNFB or Ox induced lymph node cell populations of CD8+ T cells producing interferon (IFN)-gamma and no interleukin (Il) 4 or Il-10, and CD4+ T cells producing Il-4 and Il-10 and no or little detectable IFN-gamma. The polarized patterns of cytokine production were stimulated by culture of hapten-primed lymph node cells either on anti- T cell receptor antibody-coated wells or with semipurified Langerhans cells isolated from hapten-sensitized mice. Stimulation of cytokine production during culture of hapten-primed CD4+ or CD8+ T cells with Langerhans cells was hapten specific and restricted to class II or class I major histocompatibility complex, respectively. The induction of the CD4+ and CD8+ T cells producing the polarized patterns of cytokines was not restricted to BALB/c mice, as cells from Ox sensitized C57B1/6 and B10.D2 mice produced the same patterns. Collectively, these results expose the induction of two polarized and functionally opposing populations of T cells by hapten sensitization to induce CHS: IFN-gamma-producing effector CD8+ T cells and Il-4/Il-10- producing CD4+ T cells that negatively regulate the response.

[1]  R. Tigelaar,et al.  Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. , 1990, Journal of immunology.

[2]  R. Coffman,et al.  Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo , 1993, European journal of immunology.

[3]  S. Belman,et al.  ELICITATION OF DELAYED ALLERGIC SKIN REACTIONS WITH HAPTENS: THE DEPENDENCE OF ELICITATION ON HAPTEN COMBINATION WITH PROTEIN , 1952, The Journal of experimental medicine.

[4]  R. Good,et al.  NK1.1+ CD4+ CD8‐ thymocytes with specific lymphokine secretion , 1993, European journal of immunology.

[5]  A. Enk,et al.  Induction of hapten-specific tolerance by interleukin 10 in vivo , 1994, The Journal of experimental medicine.

[6]  G. Klaus,et al.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Griffith,et al.  Regulation of contact hypersensitivity by interleukin 10 , 1994, The Journal of experimental medicine.

[8]  T. Mosmann,et al.  IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. , 1994, Journal of immunology.

[9]  M. Sy,et al.  Production of hapten-specific T cell hybridomas and their use to study the effect of ultraviolet B irradiation on the development of contact hypersensitivity. , 1989, Journal of immunology.

[10]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[11]  A. Enk,et al.  Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. , 1993, Journal of immunology.

[12]  R. Coffman,et al.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. , 1986, Journal of immunology.

[13]  T. Mosmann,et al.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. , 1987, Journal of immunology.

[14]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[15]  C. Bucana,et al.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. , 1990, Journal of immunology.

[16]  T. Mosmann,et al.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. , 1995, Immunity.

[17]  G. Asherson,et al.  The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. , 1985, Cellular immunology.

[18]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[19]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. L. Johnson,et al.  Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. , 1990, Journal of immunology.

[21]  M. Betz,et al.  Regulation and development of cytochrome c-specific IL-4-producing T cells. , 1990, Journal of immunology.

[22]  E. Palmer,et al.  Production of DNP-specific/class I MHC-restricted suppressor molecules is linked to the expression of T cell receptor alpha- and beta-chain genes. , 1993, Journal of immunology.

[23]  J. Caulfield,et al.  CELLULAR AND VASCULAR COMPONENTS OF ALLERGIC CONTACT DERMATITIS. , 1963, The American journal of pathology.

[24]  S. Knight,et al.  Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies , 1987, The Journal of experimental medicine.

[25]  P. Marrack,et al.  Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. , 1989, Journal of immunology.

[26]  A. Lanzavecchia,et al.  Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. , 1985, Journal of immunology.

[27]  K. Rajewsky,et al.  Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses , 1995, The Journal of experimental medicine.

[28]  M. Croft,et al.  Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles , 1994, The Journal of experimental medicine.

[29]  G. Trinchieri,et al.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.

[30]  J. Matriano,et al.  L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. , 1991, Cellular immunology.

[31]  H. Wigzell,et al.  Antigen specific human T cell lines specific for cobalt chloride. , 1986, Acta Dermato-Venereologica.

[32]  Y. Aragane,et al.  In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. , 1994, The Journal of investigative dermatology.

[33]  A. Enk,et al.  Identification and induction of keratinocyte-derived IL-10. , 1992, Journal of immunology.

[34]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[35]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[36]  H. Waldmann,et al.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.

[37]  M. Jenkins,et al.  In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity. , 1985, Cellular immunology.

[38]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[39]  G. Trinchieri,et al.  Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga, , 1993 .

[40]  S. Gautam,et al.  Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. , 1992, Journal of immunology.

[41]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[42]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[43]  W. Paul,et al.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 , 1994, The Journal of experimental medicine.

[44]  J. Gamble,et al.  Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression , 1976, The Journal of experimental medicine.